PharmacoEconomics & Outcomes News Weekly

, Volume 158, Issue 1, pp 10–10 | Cite as

Don’t include QOL measures in all cancer clinical trials

Newsletter Article
  • 6 Downloads

Keywords

Advisory Committee Clinical Endpoint Antineoplastic Agent Cancer Trial Antineoplastic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1998

Personalised recommendations